Cargando…

Chemotaxis of Vδ2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis

OBJECTIVES: To explore the role of Vδ2 T cells in the pathogenesis of rheumatoid arthritis (RA). METHODS: Sixty-eight patients with RA, 21 patients with osteoarthritis and 21 healthy controls were enrolled in the study. All patients with RA fulfilled the 2010 American College of Rheumatology/Europea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mo, Wen-Xiu, Yin, Shan-Shan, Chen, Hua, Zhou, Chen, Zhou, Jia-Xin, Zhao, Li-Dan, Fei, Yun-Yun, Yang, Hua-Xia, Guo, Jing-Bo, Mao, Yu-Jia, Huang, Lin-Fang, Zheng, Wen-Jie, Zhang, Wen, Zhang, Jian-Min, He, Wei, Zhang, Xuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Basic and Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705844/ https://www.ncbi.nlm.nih.gov/pubmed/28866647 http://dx.doi.org/10.1136/annrheumdis-2016-211069

Ejemplares similares

Role of LIGHT in the pathogenesis of joint destruction in rheumatoid arthritis
por: Sabokbar, Afsie, et al.
Publicado: (2017)

Dendritic cell integrin expression patterns regulate inflammation in the rheumatoid arthritis joint
por: Schittenhelm, Leonie, et al.
Publicado: (2020)

Monocyte alterations in rheumatoid arthritis are dominated by preterm release from bone marrow and prominent triggering in the joint
por: Smiljanovic, Biljana, et al.
Publicado: (2018)

Evaluation of synovial angiogenesis in patients with rheumatoid arthritis using (68)Ga-PRGD2 PET/CT: a prospective proof-of-concept cohort study
por: Zhu, Zhaohui, et al.
Publicado: (2014)

MICL controls inflammation in rheumatoid arthritis
por: Redelinghuys, Pierre, et al.
Publicado: (2016)

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
por: Bell, G M, et al.
Publicado: (2017)

Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis
por: Sohrabian, Azita, et al.
Publicado: (2018)

The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation
por: Tang, Man Wai, et al.
Publicado: (2016)

Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab
por: Herenius, M M J, et al.
Publicado: (2011)

Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis
por: Harry, Rachel A, et al.
Publicado: (2010)

Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients
por: Kabala, Pawel A, et al.
Publicado: (2020)

Study of miRNA interactome in active rheumatoid arthritis patients reveals key pathogenic roles of dysbiosis in the infection–immune network
por: Guo, Donggeng, et al.
Publicado: (2020)

Identification of a transitional fibroblast function in very early rheumatoid arthritis
por: Filer, Andrew, et al.
Publicado: (2017)

Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis
por: Tak, Paul P, et al.
Publicado: (2017)

Identification of the NF-κB activating protein-like locus as a risk locus for rheumatoid arthritis
por: Xie, Gang, et al.
Publicado: (2013)

Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis
por: Greven, D E A, et al.
Publicado: (2015)

Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis
por: Genovese, Mark C, et al.
Publicado: (2018)

Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis
por: Montgomery, Anna B, et al.
Publicado: (2016)

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
por: Boyle, D L, et al.
Publicado: (2015)

Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis
por: Leonard, Dag, et al.
Publicado: (2018)

PKCδ null mutations in a mouse model of osteoarthritis alter osteoarthritic pain independently of joint pathology by augmenting NGF/TrkA-induced axonal outgrowth
por: Kc, Ranjan, et al.
Publicado: (2016)

Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis
por: Yeo, Lorraine, et al.
Publicado: (2011)

Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis
por: Yeo, L, et al.
Publicado: (2016)

Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis
por: Schwenzer, Anja, et al.
Publicado: (2016)

Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes
por: Angiolilli, Chiara, et al.
Publicado: (2017)

Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis
por: Filková, Mária, et al.
Publicado: (2014)

Loci associated with N-glycosylation of human IgG are not associated with rheumatoid arthritis: a Mendelian randomisation study
por: Yarwood, Annie, et al.
Publicado: (2015)

Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
por: Reddy, Venkat, et al.
Publicado: (2017)

Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis
por: Jüngel, Astrid, et al.
Publicado: (2009)

Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers
por: Plant, Darren, et al.
Publicado: (2010)

Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis
por: Yeo, L, et al.
Publicado: (2015)

Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis
por: Reynolds, G, et al.
Publicado: (2016)

Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss
por: Krishnamurthy, Akilan, et al.
Publicado: (2016)

The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohort
por: Smith, Samantha Louise, et al.
Publicado: (2017)

Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis
por: Chen, Xiao-Xiang, et al.
Publicado: (2013)

Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis
por: Quirke, Anne-Marie, et al.
Publicado: (2014)

Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation
por: Alawi, Khadija M, et al.
Publicado: (2017)

Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay
por: Grabiec, Aleksander M, et al.
Publicado: (2011)

TLR1/2 and 5 induce elevated cytokine levels from rheumatoid arthritis monocytes independent of ACPA or RF autoantibody status
por: Thwaites, Ryan S, et al.
Publicado: (2020)

Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice
por: Bykerk, Vivian P, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v23kucnfgjre57bh73cgd0n38l